Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Velaglucerase_alfa> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Velaglucerase_alfa abstract "Velaglucerase alfa (trade name VPRIV), manufactured by Shire plc is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1. It has an identical amino acid sequence to the naturally occurring enzyme. It was approved for use by the U.S. Food and Drug Administration (FDA) on February 26, 2010.".
- Velaglucerase_alfa atcPrefix "A16".
- Velaglucerase_alfa atcSuffix "AB10".
- Velaglucerase_alfa fdaUniiCode "23HYE36B0I".
- Velaglucerase_alfa wikiPageID "26441610".
- Velaglucerase_alfa wikiPageRevisionID "545865825".
- Velaglucerase_alfa atcPrefix "A16".
- Velaglucerase_alfa atcSuffix "AB10".
- Velaglucerase_alfa bioavailability "N/A".
- Velaglucerase_alfa c "2532".
- Velaglucerase_alfa chembl "1201865".
- Velaglucerase_alfa chemspiderid "NA".
- Velaglucerase_alfa eliminationHalfLife "720.0".
- Velaglucerase_alfa h "3850".
- Velaglucerase_alfa hasPhotoCollection Velaglucerase_alfa.
- Velaglucerase_alfa legalStatus "Rx".
- Velaglucerase_alfa molecularWeight "55.5".
- Velaglucerase_alfa n "672".
- Velaglucerase_alfa o "711".
- Velaglucerase_alfa routesOfAdministration "Infusion".
- Velaglucerase_alfa s "16".
- Velaglucerase_alfa unii "23".
- Velaglucerase_alfa verifiedfields "changed".
- Velaglucerase_alfa verifiedrevid "470629507".
- Velaglucerase_alfa subject Category:Orphan_drugs.
- Velaglucerase_alfa subject Category:Recombinant_proteins.
- Velaglucerase_alfa type Abstraction100002137.
- Velaglucerase_alfa type Chemical114806838.
- Velaglucerase_alfa type Compound114818238.
- Velaglucerase_alfa type Macromolecule114944888.
- Velaglucerase_alfa type Material114580897.
- Velaglucerase_alfa type Matter100020827.
- Velaglucerase_alfa type Molecule114682133.
- Velaglucerase_alfa type OrganicCompound114727670.
- Velaglucerase_alfa type Part113809207.
- Velaglucerase_alfa type PhysicalEntity100001930.
- Velaglucerase_alfa type Protein114728724.
- Velaglucerase_alfa type RecombinantProtein114729633.
- Velaglucerase_alfa type RecombinantProteins.
- Velaglucerase_alfa type Relation100031921.
- Velaglucerase_alfa type Substance100019613.
- Velaglucerase_alfa type Thing100002452.
- Velaglucerase_alfa type Unit109465459.
- Velaglucerase_alfa type Drug.
- Velaglucerase_alfa type FunctionalSubstance.
- Velaglucerase_alfa comment "Velaglucerase alfa (trade name VPRIV), manufactured by Shire plc is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1. It has an identical amino acid sequence to the naturally occurring enzyme. It was approved for use by the U.S. Food and Drug Administration (FDA) on February 26, 2010.".
- Velaglucerase_alfa label "Velaglucerase alfa".
- Velaglucerase_alfa label "Velaglucerase alfa".
- Velaglucerase_alfa sameAs Velaglucerase_alfa.
- Velaglucerase_alfa sameAs m.0bbwfy6.
- Velaglucerase_alfa sameAs Q3492447.
- Velaglucerase_alfa sameAs Q3492447.
- Velaglucerase_alfa sameAs Velaglucerase_alfa.
- Velaglucerase_alfa wasDerivedFrom Velaglucerase_alfa?oldid=545865825.
- Velaglucerase_alfa isPrimaryTopicOf Velaglucerase_alfa.